This figure is directly comparable to the performance of tirzepatide (Mounjaro) in the SURMOUNT-1 trial, which showed approximately 20.9% weight loss at 72 weeks, and exceeds the approximately 14.9% achieved by semaglutide alone in STEP 1
The financial and health benefits of preventing regain often outweigh the cost of ongoing therapy
Kosowska A, Gallego-Colon E, Garczorz W, Kych-Ratuszny A, Aghdam MRF, Woz Niak M, et al
Most people see results after 5 to 10 sessions
Growth hormonereleasing hormone effects on brain -aminobutyric acid levels in mild cognitive impairment and healthy aging
This helps the body to make more insulin and stop making so much glucagon